Patents by Inventor John G. Catalano

John G. Catalano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical Compounds
    Publication number: 20220144834
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 25, 2021
    Publication date: May 12, 2022
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • Modulators of indoleamine 2,3-dioxygenase
    Patent number: 10787442
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: September 29, 2020
    Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. Catalano, Martha Alicia De La Rosa, Wieslaw Mieczyslaw Kazmierski, Vicente Samano
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20200291008
    Abstract: Provided are IDO1 inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: November 28, 2018
    Publication date: September 17, 2020
    Inventors: Wieslaw M. KAZMIERSKI, John G. CATALANO, Pek Y. CHONG
  • CHEMICAL COMPOUNDS
    Publication number: 20200255428
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
    Publication number: 20190322652
    Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
    Type: Application
    Filed: December 15, 2017
    Publication date: October 24, 2019
    Inventors: John G. CATALANO, Martha Alicia DE LA ROSA, Wieslaw Mieczyslaw KAZMIERSKI, Vicente SAMANO
  • Chemical compounds
    Patent number: 7622494
    Abstract: The present invention relates to compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: November 24, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, John G Catalano, Kristjan S Gudmundsson, Leah D'Aurora Richardson, Paul Richard Sebahar
  • Chemical Compounds
    Publication number: 20090093454
    Abstract: The present invention provides compounds of Formula (I) comprising: including salts, solvates, and physiologically functional derivatives thereof, pharmaceutical formulations containing them, processes for their preparation, and methods of treatment using them.
    Type: Application
    Filed: March 1, 2006
    Publication date: April 9, 2009
    Inventors: Kristjan Gudmundsson, John G. Catalano, Angilique Svolto
  • Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss
    Patent number: 7402606
    Abstract: Heterocycle substituted ketoamide derivatives of Formula (I), wherein the substitutes A, D, A and R are defined as in claim in, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such heterocycle substituted ketoamide derivatives as well as method of using the same in the manufacture of medicaments for the treatment of disorders, including osteoporosis, associated with an imbalance between bone resorption and formation which can ultimately lead to fracture.
    Type: Grant
    Filed: April 1, 2003
    Date of Patent: July 22, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: David Gene Barrett, John G. Catalano, David Norman Deaton, Aaron Bayne Miller, John A. Ray, Vicente Samano